Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 7680

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.23, p 0.549). This receipt's hash covers every field on it, plus the hash of receipt 7679, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 7680
    23 Oct 2026, 15:38 UTC

    NPTXR

    dopamine neurons, braak

    predictionNPTXR in dopamine neurons tracks Braak Lewy-body stage

    registeredcdafe388d6051a98

    discovery-0.23 p=0.549 n=9

    replication+0.02 p=0.964 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.23, p 0.549)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    dbc2f5c635aa2462d013ba03…
    follows ebc8b4fae7cf…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 7680: NPTXR in dopamine neurons, braak

power
full sample -0.06 (p 0.814, n 18), 95% CI -0.51 to +0.42. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.08 (p 0.761, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.28 (p 0.258, n 18). could be the mix.
skeptic
leave-one-out range -0.13 to +0.06, sign flips 4; without severely affected donors -0.06 (p 0.814, n 18). fragile.
cell type
strongest in oligodendrocytes: -0.63 (p 0.0055, n 18) vs -0.06 in dopamine neurons. proposing oligodendrocytes.
axis
no measure beats "tracks Braak Lewy-body stage" for NPTXR in dopamine neurons.

follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up NPTXR · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.52 p 0.062 (needs p < 2.7e-4)